DB
UTHR icon

Danske Bank’s United Therapeutics UTHR Stock Holding History

Danske Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.94M Buy
18,349
+1,320
+8% +$743K 0.02% 457
2026
Q1 		$10.1M Sell
17,029
-2,444
-13% -$1.22M 0.02% 429
2025
Q4 		$9.49M Buy
19,473
+3,484
+22% +$1.62M 0.02% 452
2025
Q3 		$6.7M Sell
15,989
-17,192
-52% -$5.78M 0.02% 494
2025
Q2 		$9.53M Sell
33,181
-26,103
-44% -$7.8M 0.02% 435
2025
Q1 		$18.3M Sell
59,284
-9,923
-14% -$3.4M 0.06% 289
2024
Q4 		$24.4M Sell
69,207
-26,236
-27% -$9.64M 0.07% 239
2024
Q3 		$34.2M Sell
95,443
-31,679
-25% -$10.7M 0.11% 162
2024
Q2 		$40.5M Buy
127,122
+31,607
+33% +$8.37M 0.15% 121
2024
Q1 		$21.9M Buy
+95,515
New +$21.6M 0.07% 249

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Danske Bank's UTHR Position: Q2 2026 in Review

Danske Bank increased its United Therapeutics (UTHR) stake by 7.8% in Q2 2026, buying an estimated $743K and bringing the position to 18,349 shares worth $9.94M. The position accounts for 0.02% of the portfolio, ranked #457.

Danske Bank first reported a position in UTHR in Q1 2024 and has held it in 10 quarters since. The position peaked at $40.5M in Q2 2024. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Danske Bank held 18,349 shares of United Therapeutics worth $9.94M as of Q2 2026.
  • Danske Bank bought 1,320 United Therapeutics shares in Q2 2026, an estimated $743K.
  • United Therapeutics made up 0.02% of Danske Bank's portfolio in Q2 2026, its #457 holding.
  • Danske Bank first reported a position in United Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's United Therapeutics position peaked at $40.5M in Q2 2024.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.